Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. Its products include Cytek Aurora CS ...

FREMONT, Calif., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Board of Directors has approved a stock ...

Cytek Biosciences, Inc. has announced a new stock repurchase program authorized by its Board of Directors, allowing the company to buy back up to $50 million of its common stock starting January 1 ...

FREMONT, Calif., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Board of Directors has approved a ...

U.S. stocks were lower, with the Dow Jones index falling more than 700 points on Monday. Shares of Cytek Biosciences, Inc. CTKB rose sharply during Monday's session. Cytek Biosciences announced a ...

Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report) shares traded up 5.9% during mid-day trading on Monday .The company traded as high as $6.83 and last traded at $6.77. 97,485 shares ...

Interested parties may access a live and archived webcast of these presentations on the “Investors” section of the company website at: investors.cytekbio.com. Cytek’s products are for ...

Separately, Piper Sandler upped their price objective on shares of Cytek Biosciences from $8.00 to $8.50 and gave the stock an “overweight” rating in a research report on Monday, November 11th.